TRPV4 Mediates Alveolar Epithelial Barrier Integrity and Induces ADAM10-Driven E-Cadherin Shedding
Cells · 17.10.2024 · 13 (20) · 1717
DOI: 10.3390/cells13201717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 17.10.2024. Verfasst von Lena Schaller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Walther Straub Institute for Pharmacology and Toxicology, Member of the German Center for Lung Research (DZL), Medical Faculty, LMU-Munich, Nussbaums…. Hauptthemen laut MEDLINE: Cadherins, TRPV Cation Channels, Mice, Inbred C57BL, ADAM10 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Deutsches Zentrum für Lungenforschun (DZL), Deutsche Zentrum für Lungenforschung (DZL).
Abstract (Originalsprache)
Transient receptor potential vanilloid 4 (TRPV4) channels have been associated with numerous pulmonary pathologies, including hypertension, asthma, and acute lung injury. However, their role in the alveolar epithelium remains unclear. We performed impedance-based resistance measurements in primary differentiated alveolar epithelial type I (AT1) cells from wild-type (WT) and TRPV4-deficient (TRPV4−/−) C57/BL6J mice to detect changes in AT1 barrier integrity upon TRPV4 activation. Both pharmacological (GSK1016790A) and a low pH-driven activation of TRPV4 were quantified, and the downstream effects on adherens junctions were assessed through the Western blotting of epithelial cadherin (E-cadherin) protein levels. Importantly, a drop in pH caused a rapid decrease in AT1 barrier resistance and increased the formation of a ~35 kDa E-cadherin C-terminal fragment, with both effects significantly reduced in TRPV4−/− AT1 cells. Similarly, the pharmacological activation of TRPV4 in AT1 cells triggered an immediate transient loss of barrier resistance and the formation of the same E-cadherin fragment, which was again diminished by TRPV4 deficiency. Moreover, TRPV4-mediated E-cadherin cleavage was significantly reduced by GI254023X, an antagonist of a disintegrin and metalloprotease 10 (ADAM10). Our results confirm the role of TRPV4 in regulating alveolar epithelial barrier permeability and provide insight into a novel signaling pathway by which TRPV4-induced Ca2+ influx stimulates metalloprotease-driven ectodomain shedding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Walther Straub Institute for Pharmacology and Toxicology, Member of the German Center for Lung Research (DZL), Medical Faculty, LMU-Munich, Nussbaumstrasse 26, 80336 Munich, Germany.
ORCID-Profile: Alexander Dietrich
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- Deutsches Zentrum für Lungenforschun (DZL)
- Deutsche Zentrum für Lungenforschung (DZL)
Zitieren
APA
Schaller, L., Gudermann, T., & Dietrich, A. (2024). TRPV4 Mediates Alveolar Epithelial Barrier Integrity and Induces ADAM10-Driven E-Cadherin Shedding. Cells, 13(20), 1717. https://doi.org/10.3390/cells13201717
Vancouver
Schaller L, Gudermann T, Dietrich A. TRPV4 Mediates Alveolar Epithelial Barrier Integrity and Induces ADAM10-Driven E-Cadherin Shedding. Cells. 2024;13(20):1717. doi:10.3390/cells13201717
BibTeX
@article{Schaller2024,
author = {Schaller, Lena and Gudermann, Thomas and Dietrich, Alexander},
title = {TRPV4 Mediates Alveolar Epithelial Barrier Integrity and Induces ADAM10-Driven E-Cadherin Shedding},
journal = {Cells},
year = {2024},
volume = {13},
number = {20},
pages = {1717},
doi = {10.3390/cells13201717}
}
EUVIMED